Publications

• Medical Education in Dermatology.Imaeda S, Tomayko MM. Clin Dermatol. 2024 Dec 14; 2024 Dec 14. PMID: 39681292.
• Psychosocial burden of autoimmune blistering diseases: A comprehensive survey study.White MA, Hoffman VM, Yale M, Strong R, Tomayko MM. J Eur Acad Dermatol Venereol. 2024 Jun 4; 2024 Jun 4. PMID: 38837452.
• Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy: reply from the authors.Shipman WD, Singh K, Cohen JM, Leventhal J, Damsky W, Tomayko MM. Br J Dermatol. 2023 Dec 20. PMID: 37947404.
• Polyinosinic: polycytidylic acid induced inflammation enhances while lipopolysaccharide diminishes alloimmunity to platelet transfusion in mice.Tran JQ, Muench MO, Gaillard B, Darst O, Tomayko MM, Jackman RP. Front Immunol. 2023; 2023 Dec 11. PMID: 38146372.
• Enhanced alloresponse to platelet transfusion due to immune dysregulation following ablative chemotherapy in mice.Jackman RP, Darst O, Gaillard B, Tran JQ, Tomayko MM, Muench MO. Front Immunol. 2023; 2023 Nov 27. PMID: 38090570.
• Bulk and single-nucleus RNA sequencing highlight immune pathways induced in individuals during an Ixodes scapularis tick bite.Tang X, Lynn GE, Cui Y, Cerny J, Arora G, Tomayko MM, Craft J, Fikrig E. Infect Immun. 2023 Nov 16; 2023 Oct 17. PMID: 37846980.
• Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection.Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, Kwan JM, Buitrago-Pocasangre NC, Lele N, Asashima H, Racke MK, Wilson JE, Givens TS, Tomayko MM, Schulz WL, Longbrake EE, Hafler DA, Halene S, Fan R. Small Methods. 2023 Oct; 2023 Jun 13. PMID: 37312418.
• High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq.Liu Y, DiStasio M, Su G, Asashima H, Enninful A, Qin X, Deng Y, Nam J, Gao F, Bordignon P, Cassano M, Tomayko M, Xu M, Halene S, Craft JE, Hafler D, Fan R. Nat Biotechnol. 2023 Oct; 2023 Feb 23. PMID: 36823353.
• Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatment.Shipman WD, Singh K, Cohen JM, Leventhal J, Damsky W, Tomayko MM. Br J Dermatol. 2023 Aug 24. PMID: 37140007.
• Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination.Asashima H, Kim D, Wang K, Lele N, Buitrago-Pocasangre NC, Lutz R, Cruz I, Raddassi K, Ruff WE, Racke MK, Wilson JE, Givens TS, Grifoni A, Weiskopf D, Sette A, Kleinstein SH, Montgomery RR, Shaw AC, Li F, Fan R, Hafler DA, Tomayko MM, Longbrake EE. JCI Insight. 2023 Aug 22; 2023 Aug 22. PMID: 37606046.
• Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity.Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, Kwan JM, Buitrago-Pocasangre NC, Lele N, Asashima H, Racke MK, Wilson JE, Givens TS, Tomayko MM, Schulz WL, Longbrake EE, Hafler DA, Halene S, Fan R. bioRxiv. 2022 Sep 2; 2022 Sep 2. PMID: 36093346.
• Spatial-CITE-seq: spatially resolved high-plex protein and whole transcriptome co-mapping.Liu Y, DiStasio M, Su G, Asashima H, Enninful A, Qin X, Deng Y, Bordignon P, Cassano M, Tomayko M, Xu M, Halene S, Craft JE, Hafler D, Fan R. Res Sq. 2022 Mar 30; 2022 Mar 30. PMID: 35378748.
• A novel NFkB1 mutation linking pyoderma gangrenosum and common variable immunodeficiency.Sun Q, Gehlhausen JR, Freudzon M, Kibbi N, Bale A, Choate K, Tomayko M, Odell I, Ramachandran S. JAAD Case Rep. 2021 Dec; 2021 Oct 29. PMID: 34825039.
• Targeting the FcRn: A Novel Approach to the Treatment of Pemphigus.Nelson CA, Tomayko MM. J Invest Dermatol. 2021 Dec; 2021 Sep 23. PMID: 34565557.
• Modifying a comprehensive preclinical dermatology curriculum to better teach dermatology in skin of all colors: Response to "Improving cultural competency and practicing cultural humility in dermatologic training: Skin of color education and board certification".Zhou AG, Hafler J, Tomayko MM. J Am Acad Dermatol. 2021 Dec; 2021 Aug 8. PMID: 34375668.
• Memory B cells and plasma cells: The differentiative continuum of humoral immunity.Cancro MP, Tomayko MM. Immunol Rev. 2021 Sep; 2021 Aug 15. PMID: 34396546.
• Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination.Tomayko MM, Damsky W, Fathy R, McMahon DE, Turner N, Valentin MN, Rallis T, Aivaz O, Fox LP, Freeman EE. J Allergy Clin Immunol. 2021 Sep; 2021 Jul 15. PMID: 34275656.
• Roles of Bone Morphogenetic Protein Receptor 1A in Germinal Centers and Long-Lived Humoral Immunity.Tomayko MM, Karaaslan S, Lainez B, Conter LJ, Song E, Venkatesan S, Mishina Y, Shlomchik MJ. Immunohorizons. 2021 May 11; 2021 May 11. PMID: 33975878.
• A Niche for Plasma Cells: The Skin.Karaaslan S, Tomayko MM. J Invest Dermatol. 2019 Dec. PMID: 31753124.
• B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors.Damsky W, Jilaveanu L, Turner N, Perry C, Zito C, Tomayko M, Leventhal J, Herold K, Meffre E, Bosenberg M, Kluger HM. J Immunother Cancer. 2019 Jun 14; 2019 Jun 14. PMID: 31200747.
• What B cell memories are made of.Tomayko MM, Allman D. Curr Opin Immunol. 2019 Apr; 2019 Mar 9. PMID: 30861463.
• Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.Coleman E, Ko C, Dai F, Tomayko MM, Kluger H, Leventhal JS. J Am Acad Dermatol. 2019 Apr; 2018 Nov 3. PMID: 30399387.
• Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.Siegel J, Totonchy M, Damsky W, Berk-Krauss J, Castiglione F Jr, Sznol M, Petrylak DP, Fischbach N, Goldberg SB, Decker RH, Stamatouli AM, Hafez N, Glusac EJ, Tomayko MM, Leventhal JS. J Am Acad Dermatol. 2018 Dec; 2018 Jul 17. PMID: 30025829.
• Bullous systemic lupus erythematosus in a 6-year-old boy.Li AW, Weed JG, Stamey CR, Subtil A, Tomayko MM, Antaya RJ. Pediatr Dermatol. 2017 Nov; 2017 Aug 29. PMID: 28851077.
• Podoplanin is a negative regulator of Th17 inflammation.Nylander AN, Ponath GD, Axisa PP, Mubarak M, Tomayko M, Kuchroo VK, Pitt D, Hafler DA. JCI Insight. 2017 Sep 7; 2017 Sep 7. PMID: 28878118.
• Development of bullous pemphigoid during nivolumab therapy.Damsky W, Kole L, Tomayko MM. JAAD Case Rep. 2016 Nov; 2016 Dec 3. PMID: 27981213.
• CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype.Zuccarino-Catania GV, Sadanand S, Weisel FJ, Tomayko MM, Meng H, Kleinstein SH, Good-Jacobson KL, Shlomchik MJ. Nat Immunol. 2014 Jul; 2014 Jun 1. PMID: 24880458.
• CD73 expression is dynamically regulated in the germinal center and bone marrow plasma cells are diminished in its absence.Conter LJ, Song E, Shlomchik MJ, Tomayko MM. PLoS One. 2014; 2014 Mar 24. PMID: 24664100.
• Multiple transcription factor binding sites predict AID targeting in non-Ig genes.Duke JL, Liu M, Yaari G, Khalil AM, Tomayko MM, Shlomchik MJ, Schatz DG, Kleinstein SH. J Immunol. 2013 Apr 15; 2013 Mar 20. PMID: 23514741.
• Cutting edge: Hierarchy of maturity of murine memory B cell subsets.Tomayko MM, Steinel NC, Anderson SM, Shlomchik MJ. J Immunol. 2010 Dec 15; 2010 Nov 15. PMID: 21078902.
• PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.Good-Jacobson KL, Szumilas CG, Chen L, Sharpe AH, Tomayko MM, Shlomchik MJ. Nat Immunol. 2010 Jun; 2010 May 9. PMID: 20453843.
• BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.Scholz JL, Crowley JE, Tomayko MM, Steinel N, O'Neill PJ, Quinn WJ 3rd, Goenka R, Miller JP, Cho YH, Long V, Ward C, Migone TS, Shlomchik MJ, Cancro MP. Proc Natl Acad Sci U S A. 2008 Oct 7; 2008 Oct 1. PMID: 18832171.
• Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities.Tomayko MM, Anderson SM, Brayton CE, Sadanand S, Steinel NC, Behrens TW, Shlomchik MJ. J Immunol. 2008 Jul 1. PMID: 18566367.
• New markers for murine memory B cells that define mutated and unmutated subsets.Anderson SM, Tomayko MM, Ahuja A, Haberman AM, Shlomchik MJ. J Exp Med. 2007 Sep 3; 2007 Aug 13. PMID: 17698588.
• Intrinsic properties of human and murine memory B cells.Anderson SM, Tomayko MM, Shlomchik MJ. Immunol Rev. 2006 Jun. PMID: 16824135.
• Characterization of mouse tGolgin-1 (golgin-245/trans-golgi p230/256 kD golgin) and its upregulation during oligodendrocyte development.Cowan DA, Gay D, Bieler BM, Zhao H, Yoshino A, Davis JG, Tomayko MM, Murali R, Greene MI, Marks MS. DNA Cell Biol. 2002 Jul. PMID: 12162805.